Skip to content
Screener

Abbott ABT Other Income (Expense)

Other Income (Expense) at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$24.2M-34.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$331M-209%
Haemonetics logo
HaemoneticsHAE
-$9.88M-13.6%
Artivion logo
ArtivionAORT
$3.55M-28.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$9.39M+405%
DexCom logo
DexComDXCM
-$800K-103%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$186.81B-18.0%
Enterprise value$214.32B-8.6%
P/E34.4×+18.1×
P/S-1.3×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134
Line itemThree Months Ended / June 30 / 2026Three Months Ended / June 30 / 2025Six Months Ended / June 30 / 2026Six Months Ended / June 30 / 2025
Interest expense351121525252
Interest (income)(52)(71)(158)(153)
Net foreign exchange (gain) loss4(11)(9)(18)
Other (income) expense, net(134)(137)(293)(264)
Earnings before taxes1,5242,1502,9733,928
Taxes on earnings596371968824
Net Earnings$928$1,779$2,005$3,104
Basic Earnings Per Common Share$0.53$1.02$1.15$1.78

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's other income (expense)?
Abbott (ABT) reported other income (expense) of $134M in Q2 2026.
How has Abbott's other income (expense) changed year-over-year?
Abbott's other income (expense) decreased by 2.2% year-over-year, from $137M to $134M.
What is the long-term trend for Abbott's other income (expense)?
Over 4 years (2021 to 2025), Abbott's other income (expense) has grown at a 18.6% compound annual growth rate (CAGR), from $277M to $548M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Abbott's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude